Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Filings indexed 568 across all filing types
Latest filing 2022-04-28 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
第二届监事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th meeting of the 2nd Supervisory Board of Huizhou Jin Hao Medical Technology Co., Ltd. It details meeting attendance, agenda items, voting results, and adjustments to the 2022 equity incentive plan. The content focuses on board-level decisions and management matters, specifically related to stock option grants and adjustments. There is no indication of financial statements, audit results, or regulatory filings beyond the meeting resolutions. The document is not a full annual or interim report, nor is it a call transcript or earnings release. It is not a proxy solicitation or voting result announcement for a shareholder meeting but rather a board/management information disclosure about internal decisions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and focused on management decisions, supporting this classification with high confidence.
2022-04-28 Chinese
第二届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Huizhou Jin Hao Medical Technology Co., Ltd. It details the convening and attendance of the meeting, the approval of the first quarter 2022 report, and references the actual quarterly report published separately on the Beijing Stock Exchange website. The document itself does not contain the financial data or the full quarterly report but rather announces the resolution passed regarding the report. The document length is short (733 characters), and it explicitly states that the detailed quarterly report is disclosed elsewhere. Therefore, this document is an announcement of a meeting resolution related to a quarterly report, not the report itself. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-04-24 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 2nd Board of Directors of Huizhou Jin Hao Medical Technology Co., Ltd. It includes details about the meeting date, attendance, and voting results on specific proposals such as approval of the 2022 Q1 report and a credit loan renewal. The document does not contain the full quarterly report itself but references it as disclosed elsewhere (announcement number 2022-045). The content focuses on board meeting decisions and management-level approvals rather than the full financial report or earnings release. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and management decisions.
2022-04-24 Chinese
关于2022年第一季度报告变更披露日期的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (409 characters) regarding a change in the disclosure date of the company's 2022 first quarter report. It does not contain the actual quarterly report or financial data, but only informs about the rescheduling of the report release date. According to the 'MENU VS MEAL' rule, such a brief notice about report timing is classified as a Report Publication Announcement (RPA).
2022-04-24 Chinese
2022年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022年第一季度报告" which translates to "2022 First Quarter Report". It contains detailed financial data for the period from January 1, 2022 to March 31, 2022, including balance sheet figures, income statement data, cash flow, earnings per share, and other financial metrics. The document also includes sections on company basic information, major events, and compliance with disclosure obligations. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which is a comprehensive financial report for a period shorter than a full fiscal year and contains substantive financial data and analysis. There is no indication that this is an annual report, audit report, or other filing types. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2022
2022-04-24 Chinese
关于认定核心员工的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the recognition of core employees, including details of board and supervisory meetings, employee nominations, and shareholder approval. It does not contain financial statements, earnings data, or detailed management discussion. It is not a report or presentation but an official announcement related to internal company personnel decisions. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2022-04-19 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.